Evolus Inc (EOLS NASDAQ) stock market data APIs
$6.5161
0.61(9.4%)
as of November 7, 2025
Try our APIs with
free plan!
Evolus Inc Financial Data Overview
Price chart is built with
Anychart
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Prev. Close
6.5161
Open
7.1265
High
7.3178
Low
6.5211
52 wk Range
5.71-17.12
Market Cap
425 M
Shares Outstanding
64 820 K
Revenue
286 M
EPS
-0.1478
Beta
0.881
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Evolus Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Evolus Inc data using free add-ons & libraries
Get Evolus Inc Fundamental Data
Evolus Inc Fundamental data includes:
- Net Revenue: 286 M
- EBITDA: -31 495 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: -0.1467
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evolus Inc News
New
Evolus (EOLS) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool. Date Wednesday, Nov. 5, 2025, at 4:30 p.m. ET Call participants Chief Executive Officer — David Moatazedi Chief Financial Officer — Tatiana Mitchell Chief Medica...
Medtech Stocks Reignite After Hours: RxSight, Penumbra, Evolus Lead The Charge
(RTTNews) - Several healthcare and medtech stocks staged notable rebounds in after-hours trading Wednesday, with gains driven by updated guidance, margin improvements, and signs of operational resilie...
Evolus, Inc. (EOLS) Reports Q3 Loss, Beats Revenue Estimates
Evolus, Inc. (EOLS) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.19 per share a year ago. These figures are a...
Earnings Preview: Prestige Consumer Healthcare (PBH) Q2 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when Prestige Consumer Healthcare (PBH) reports results for the quarter ended September 2025. While this widely-known consens...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
